Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tree

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
Nature Medicine|July 30, 2024
Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trialDanijela Tatovic, Ashish Marwaha, Peter Taylor, et al.
Science Translational Medicine|August 11, 2017
Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetesMohammad Alhadj Ali, Yuk-Fun Liu, Sefina Arif, et al.
Nature|February 19, 2025
Clonal driver neoantigen loss under EGFR TKI and immune selection pressuresMaise Al Bakir, James L Reading, Samuel Gamble, et al.
European Journal of Immunology|December 15, 2021
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)Andrea Cossarizza, Hyun-Dong Chang, Andreas Radbruch, et al.
European Journal of Immunology|October 22, 2019
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)Andrea Cossarizza, Hyun-Dong Chang, Andreas Radbruch, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
Nature Medicine|July 30, 2024
Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trialDanijela Tatovic, Ashish Marwaha, Peter Taylor, et al.
Science Translational Medicine|August 11, 2017
Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetesMohammad Alhadj Ali, Yuk-Fun Liu, Sefina Arif, et al.
Nature|February 19, 2025
Clonal driver neoantigen loss under EGFR TKI and immune selection pressuresMaise Al Bakir, James L Reading, Samuel Gamble, et al.
European Journal of Immunology|December 15, 2021
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)Andrea Cossarizza, Hyun-Dong Chang, Andreas Radbruch, et al.
European Journal of Immunology|October 22, 2019
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)Andrea Cossarizza, Hyun-Dong Chang, Andreas Radbruch, et al.
Pageof 12